TRAF2 and breast carcinoma: Furthermore, Janus et al.77 report that HSF1 can attenuate pro-inflammation by inhibiting candidate genes involved in the NFκB pathway, including NFκB inhibitor delta, TNF receptor-associated factor 2, and TNF receptor-associated factor 3 in human MCF7 ERα-positive breast cancer cells.